Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top California based Director operating in the Medical space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Mariam Iqbal
Director Of Procurement of AstraZeneca
Follow Mariam Iqbal:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Neil Poloso
Executive Director, Biological Research of Allergan
Follow Neil Poloso:
About AbbVie, Allergan: Allergan is a global pharmaceutical company.
Tory Brady
Director of Product Engineering of Allergan
Tory Brady’s passion is building software with a keen eye on the customer and the jobs they’re hiring a product to do in their lives. He loves when beautiful design, performant code and comprehensive data intersect. He’s had a fruitful career as a Software Engineer, working for a variety of technology start-ups. Now Tory is applying these learned start-up methodologies to Allergan’s medical aesthetics business as they work to revitalize the digital relationship with their consumers.
Follow Tory Brady:
About Allergan: Allergan is a global pharmaceutical company.
Amy Tenderich
Editorial Director, Diabetes & Patient Advocacy at Healthline.com of Healthline Media
Follow Amy Tenderich:
About DiabetesMine.com, DiabetesMine.com, Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Diane Gaswirth
Sales Director of UnitedHealth Group
Diane Gaswirth, B.S., M.S., is the sales director in San Diego county for UnitedHealthcare Medicare Solutions. She is responsible for growing membership in the Medicare portfolio of products. Prior, Diane was the sales manager for SecureHorizons/Pacificare and served in advertising, educational and service roles at Blue Cross of California. She also completed the Center of Excellence in Healthcare Management course through the University of Southern California.
Follow Diane Gaswirth:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Ian Van Every
Co-Founder & UK Managing Director of Lemonaid Health
Follow Ian Van Every:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Bret Henning
Sr Director and Information Technology of Tandem Diabetes Care
Bret Henning is currently the Sr. Director of Information Technology at Tandem Diabetes Care, Inc. Bret is responsible for worldwide IT operations including infrastructure, cloud computing, collaboration technologies, enterprise applications, DEVOPS, call center and voice technologies. At Tandem Bret was involved in building the company from an early stage startup through product commercialization. He brings a diverse portfolio of experience managing everything from Facilities to Connected Heath. His background includes more than 30 years of hands-on experience in technology for electronics and medical device companies.
Follow Bret Henning:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Alex Milligan
Co-founder & Marketing Director of Nugg
Follow Alex Milligan:
About Nugg: Nugg allows mmj patients to find and order cannabis-based products from nearby collectives that deliver or offer pickup.
Nicolas Sauvage
Managing Director of TDK Ventures
Managing Director of TDK Ventures. TDK Ventures is a technology-focused venture fund, investing globally in early-stage startups that leverages fundamental material science to unlock an attractive and sustainable future for the world. TDK Ventures goal is to help every start-up we invest to achieve their full potential for positive world impact. He was previously responsible at InvenSense for all strategic ecosystem relationships, including Google and Qualcomm, and other HW/SW/System companies. Before that, Nicolas was part of NXP Software management team, responsible for worldwide sales, and later P&L and product management of the OEM Business Line. Nicolas is an alumnus of Stanford, INSEAD, Institut supérieur d’électronique et du numérique and London Business School
Follow Nicolas Sauvage:
About TDK Corporation, TDK Ventures, TDK Ventures: TDK Ventures is the Corporate VC arm of TDK Corporations that invests globally in hard-tech entrepreneurs.
Bray Patrick-Lake
Director, Strategic Partnerships of Evidation Health
Bray is the Director of Strategic Partnerships at Evidation Health. She develops collaborations to support the design and implementation of participant-centered studies, and serves on the All of Us National Advisory Panel, the Digital Medicine Society Scientific Leadership Board, and the National Academies of Sciences, Engineering, and Medicine (NASEM) Health Science Policy Board. Previously, Bray led engagement for the Duke Clinical Research Institute Project Baseline Study Coordinating Center and served as co-chair on the Advisory Committee to the NIH Director that authored the Precision Medicine Initiative’s Cohort Program. Bray holds a BS degree from the University of Georgia, and an MFS degree from National University.
Follow Bray Patrick-Lake:
About Evidation Health: We enable and empower everyone to participate in better health outcomes.
Bret Evans
Sr Director IT of Johnson & Johnson
Currently Bret is the Sr. Director of IT Supply Chain for Johnson & Johnson Ethicon & CSS business.
Follow Bret Evans:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Gillian Hanson
Director, Data & Informatics of PicnicHealth
Follow Gillian Hanson:
About PicnicHealth: PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Konstantin Guericke
Member of the Board of Directors of StartX (Stanford-StartX Fund)
Konstantin Guericke is a Partner at Earlybird. He is based in Silicon Valley. Konstantin is Co – Founder of LinkedIn, where he has led marketing activities from launch to first six million members and profitability as Vice President of Marketing. Previously, he has been CEO of jaxtr (social communications start-up, over ten million registered users, purchased by SabSe Technologies). Konstantin has long-time entrepreneurial experience as founder of successful startups and he has helped established companies towards increased growth. Currently, he is Board member of several startups and Mentor of student entrepreneurs at Stanford University. Konstantin holds a B.S. and M.S. in Engineering from Stanford University.
Follow Konstantin Guericke:
About : StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Dan Ha
Co-Founder, Sr. Managing Director of StartX (Stanford-StartX Fund)
Follow Dan Ha:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Margi McLoughlin
Executive Director of Pfizer
Margi McLoughlin, PHD is Executive Director, WWBD and Partner at Pfizer Ventures. Margi invests in companies working in areas aligned with the future directions of Pfizer. She currently has responsibility for Pfizer’s investments in 4D Molecular Therapeutics, Adapsyn, BioAtla, Cortexyme and System1. Through these investments, she works with the companies to help advance products and technologies of value to the pharmaceutical industry. Margi began her career at Mallinckrodt Medical, holding positions in Discovery Research, followed by Technology Planning. In 1999, she moved to Yale University where she worked as Associate Director in the Office of Cooperative Research. Since joining Pfizer Worldwide Business Development in 2001, she has had roles of increasing responsibility and led transactions with multiple biotech companies, including Ablexis, Gliknik and Excaliard. In addition, Margi played a significant role in defining Pfizer’s Centers for Therapeutic Innovation business model.
Follow Margi McLoughlin:
About Pfizer, Pfizer Venture Investments: Pfizer provides access to safe and effective and affordable medicines and health care services.
Colton Pierson
Director Of Engineering of Curative
Follow Colton Pierson:
About Curative: Curative is a leader in on-demand public health programs and infrastructure. We’re building a healthier tomorrow, together.
Robert Gentleman
Executive Director of Harvard Medical School
Follow Robert Gentleman:
About Harvard Medical School: Harvard Medical School is a medical education and scientific research institution focused on education, research, clinical care and service.
Samara Freeman
Director, IP & Regulatory Affairs of Evolve Biosystems
Samara was one of the co-founders of Evolve Biosystems. Samara has qualifications in both science and management and has worked in research management and biotech in the US and internationally. Samara has co-authored numerous scientific articles and is an invited and keynote speaker at milk and dairy conferences.
Follow Samara Freeman:
About Evolve Biosystems, Evolve Biosystems: Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.
Elizabeth Swanson
Director, Human Resources of Cue
Elizabeth Swanson is a Director, Human Resources at Cue Health Inc.
Follow Elizabeth Swanson:
About Cue: Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep.
Andrew Hudak
Senior Director, Program Management of Cue
Andrew Hudak is the Sr. Director of Program Management at Cue Inc.
Follow Andrew Hudak:
About Cue: Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep.
Deborah Morris
Director of Regulatory and Clinical Affairs of Cue
Deborah Morris is the Director of Regulatory and Clinical Affairs at Cue Health Inc.
Follow Deborah Morris:
About Cue: Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep.
Steve Venz
Director of Automation of Cue
Steve Venz is the Director of Automation at Cue Inc.
Follow Steve Venz:
About Cue: Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep.
Dave Ferrera
Director of Blockade Medical
Dave is Chief Technology Officer of Balt and a seasoned medical device executive with 20 years of experience working within the medical device and interventional neurovascular industry. Prior to Balt’s acquisition of Blockade Medical in 2016, he was a co-founding member of Blockade Medical, he also served as VP Product Development/Clinical Research & General Manager of MindFrame Inc.(acquired by Covidien in 2012), a developer, manufacturer and marketer of minimally invasive products for the treatment of acute ischemic stroke based in Irvine, CA. Prior to that he served as Director of Clinical Research/R&D for Microvention (acquired by Terumo in 2006), a developer, manufacturer and marketer of minimally invasive products for treatment of cerebral and vascular peripheral diseases based in Aliso Viejo, CA. His past roles have included Director of Technology Development of Micrus Endovascular (IPO in 2004 and acquired by J&J/Codman in 2010), Sr. R&D/Pilot Engineer of Boston Scientific in Watertown, MA, and R&D Process Engineer at IMPRA, Inc. in Tempe, AZ (acquired by C.R. Bard in 1996). Dave received a B.S. in Plastics Engineering from University of Lowell, in Lowell, Massachusetts. He holds several US and international patents for medical devices.
Follow Dave Ferrera:
About Balt, Blockade Medical, Sage Executive Group, Treadstone Holdings LLC: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Melissa Lee
Director of Community Relations of Bigfoot Biomedical
Follow Melissa Lee:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Melissa Lee
Director of Community Relations of Bigfoot Biomedical
Follow Melissa Lee:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Merinda Do
Global Director of Human Resources of Paramit Corporation
Merinda joined Paramit in 2005 as the Director of Human Resources. She is responsible for all HR and employee development functions. Prior to joining Paramit, Merinda has held various HR Management positions at Zeta Defense Technology, CMAC, Solectron, and Fortinet. Merinda holds a BS in Economics Management, SPHR certified, and is a member of NCHRA, SHRM.
Follow Merinda Do:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Mano Aryapour
Sr. Director of Program Management of Paramit Corporation
Mano Aryapour is the Senior Director, Program Management at Paramit Corp.
Follow Mano Aryapour:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Aenor Sawyer
Director, University of California, Space Health; Dir. Skeletal Health Service of University of California, San Francisco
Aenor Sawyer is an Orthopaedic Surgeon at UCSF and Associate Director of Digital Health in Biomedical Informatics at the Clinical & Translational Science Institute where she co-directs the UCSF T1 Catalyst Digital Health Grants program. Aenor Sawyer is also co-Founder of Trinity, a web-based collaboration technology for Virtual Tumor Board and Multidisciplinary Management of complex patients.
Follow Aenor Sawyer:
About Translational Research Institute for Space Health (TRISH), Trinity Labs, University of California, San Francisco: Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Sanchita Bhattacharya
Scientific Program Director of University of California, San Francisco
Sanchita Bhattacharya is the Bioinformatics Project Lead at UCSF School of Medicine.
Follow Sanchita Bhattacharya:
About UCSF School of Medicine, University of California, San Francisco: Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Daniel Lowenstein
Director, Physician-Scientist Education & Training of University of California, San Francisco
Daniel Lowenstein is the Director, Physician-Scientist Education & Training at UCSF.
Follow Daniel Lowenstein:
About University of California, San Francisco, University of California, San Francisco, University of California, San Francisco: Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Ivan Lai
Senior Director, Global Supply Chain of Stryker
Follow Ivan Lai:
About Dexcom, Koderon, Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Mark Mastandrea
Senior Director, Supply Chain of Stryker
Follow Mark Mastandrea:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Tristan Wyatt
Director of VA of LIM Innovations
Tristan Wyatt is Director of VA at LIM Innovations.
Follow Tristan Wyatt:
About LIM Innovations: At LIM Innovations we empower amputees by creating custom, innovative, sustainable and accessible prosthetic sockets.
Samantha Cardenas
Director of Operations of Surglogs
Samantha Cardenas is the Director of Operations at SurgLogs.
Follow Samantha Cardenas:
About Surglogs: Surglogs streamlines and automates administration of logbooks, medications, supplies, in-services and drills in healthcare facilities.
David Cory
President and Chief Executive Officer, Board Director of Eiger BioPharmaceuticals
David Cory is an entrepreneur and industry veteran with 25-years experience in large pharmaceuticals, emerging stage biotechnology, and specialty pharmaceutical organizations with an established track record of operational, transactional, and financial success.Mr. Cory is currently the President and CEO of Eiger BioPharmaceuticals since 2008. He is responsible for negotiating Eiger’s multiple product licenses from Merck and Astra Zeneca. Cory was previously President and Chief Operating Officer of Prestwick Pharmaceuticals, an Orphan CNS specialty pharmaceutical company, which was acquired by Biovail Pharmaceuticals for $160 million in 2008. Cory was Co-Founder and Chief Commercial Officer at CoTherix, an Orphan Pulmonary Hypertension company, which was acquired by Actelion for $425 million in 2006. Cory began his start up career as Senior Vice President of Commercial Operations at InterMune, a public biotechnology company focused on developing Orphan products for Idiopathic Pulmonary Fibrosis. He was as a key executive in the InterMune IPO, building and managing the company’s commercial organization, in-licensing 4 products and raising over $400 million in the capital markets. Mr. Cory spent the first 12 years of his career in operating positions of increasing responsibility at The Upjohn Company, Glaxo, Glaxo Wellcome, and Glaxo Smith Kline leading teams in CNS, Critical Care, Oncology, Infectious Disease, and Respiratory therapeutic areas, where he directed 10 pharmaceutical product launches and the commercialization of 20 brands.David Cory is a graduate of the University of Cincinnati, College of Pharmacy, is board certified in Pharmacy, and holds a Masters Degree in Business Administration from the University of Maryland.
Follow David Cory:
About Eiger BioPharmaceuticals: Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.
Nicholas J. Simon
Managing Director of The Blackstone Group Inc
Nicholas Simon has been a Managing Director of Clarus since the firm’s inception in 2005. Prior to Clarus, Nicholas Simon was a General Partner at MPM Capital, a healthcare venture capital firm. He has over 20 years of operating and investment experience in the biopharmaceutical industry including Genentech from 1989 to 2000 where he was Vice President of Business and Corporate Development. Nicholas Simon received a BS degree in microbiology from the University of Maryland and an MBA from Loyola University. Nicholas Simon is a Trustee at The J David Gladstone Institutes, a private not-for-profit research institute affiliated with the University of California, San Francisco.
Follow Nicholas J. Simon:
About Blackstone Life Sciences, ITM Solutions, The Blackstone Group Inc: Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
James Atkinson
Medical Director of UCLA Health System
Follow James Atkinson:
About UCLA Health System: UCLA Health has provided the best in healthcare and the latest in medical technology to the people of Los Angeles and throughout the world.
David Heber
Professor and Director, Center for Human Nutrition of UCLA Health System
David Heber is internationally prominent in the fields of nutrition, metabolism, obesity and its associated complications. He has published seminal research articles on the causes of obesity, weight loss strategies, and the relationship of obesity to cancer and cardiovascular disease. David Heber is the Founding Director of the UCLA Center for Human Nutrition at the University of California, Los Angeles, a Professor of Medicine and Public Health, the founding Chief of the Division of Clinical Nutrition in the Department of Medicine.He directs the NCI-funded Clinical Nutrition Research Unit and the NIH Nutrition and Obesity Training Grants at UCLA. Heber is board-certified in Internal Medicine, and Endocrinology and Metabolism by the American Board of Internal Medicine and in Clinical Nutrition by the American Board of Nutrition. He earned his MD at Harvard Medical School and his Ph.D. in Physiology at the University of California, Los Angeles. Heber served as a Director of the American Board of Nutrition and past chair of the Education Committee of the American Society of Clinical Nutrition. He is included in the 2000 listing of The Best Doctors in America, based on a survey of over 35,000 doctors throughout the nation, and is listed in Who’s Who in America for 2001. Heber’s primary areas of research are obesity treatment and prevention, the role of nutrition, phytochemicals,and botanical dietary supplements in the prevention and treatment of common forms of cancer and cardiovascular disease. He is the author of over 100 peer-reviewed scientific articles, 25 book chapters, and two professional texts.
Follow David Heber:
About UCLA Health System: UCLA Health has provided the best in healthcare and the latest in medical technology to the people of Los Angeles and throughout the world.
Rachel Linonis
Title Director of Digital Solutions, UCLA Division of Population Behavioral Health of UCLA Health System
Follow Rachel Linonis:
About UCLA Health System: UCLA Health has provided the best in healthcare and the latest in medical technology to the people of Los Angeles and throughout the world.
Geoffrey Parker
Board of Directors of ChemoCentryx
Geoffrey M. Parker has served as our Senior Vice President and Chief Financial Officer since September 2010, after serving in a consulting capacity since December 2009. From July 2009 to July 2010, Mr. Parker served in a consulting capacity as the Chief Business Officer of InteKrin Therapeutics, a privately held biopharmaceutical company in Los Altos, California. From 1997 to April 2009, Mr. Parker was a Vice President, then Managing Director and finally Partner at the global investment banking and securities firm Goldman Sachs Group, Inc., leading their West Coast Healthcare Investment Banking practice during this time. Mr. Parker also served in various capacities with Goldman Sachs Group, Inc. from 1990 to 1995 and 1986 to 1988. From 1995 to 1997, Mr. Parker was Vice President at Feibusch & Co., a venture capital firm in Larkspur, California. Mr. Parker is currently a member of the board of directors of Genoptix, Inc., a specialized laboratory service provider and ChemoCentryx, Inc., a clinical stage privately held biopharmaceutical company. Mr. Parker received an A.B. from Dartmouth College in Engineering Sciences and Economics and an M.B.A. from Stanford University.
Follow Geoffrey Parker:
About Tricida: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Sam Hanash
Director of MD &erson’s Red & Charline McCombs Institute for the Early Detection & Treatment of The University of Texas M.D. Anderson Cancer Center
I was recruited to join MD Anderson in July 2012 to lead the Red and Charline McCombs Institute for Cancer Early Detection and Treatment of Cancer. My interests and expertise focus on the development and application of integrated approaches for the molecular profiling of cancer, with emphasis on the application of proteomics technologies for the development of blood based markers to identify subjects at increased risk of developing cancer and markers for early detection of cancer and for tumor classification. The work involves sorting through tens of thousands of protein forms in the blood most of which occur at exceedingly low abundance to identify those that are most relevant to particular cancer types. I serve as program principal investigator for many multi-investigator projects aimed at discovery and validation of cancer markers. I led a consortium of investigators working on molecular profiling of lung cancer to identify molecular risk factors for developing lung cancer among smokers as well never smokers that can be used to develop a blood test for lung cancer risk. Another goal is to develop blood based markers for the early detection of lung cancer. I have also led similar efforts to identify markers for the early detection of other cancers notably breast, ovarian, pancreas and colon. I pioneered strategies for the discovery of cancer markers which include molecular profiling of blood that was collected one or more years prior to a diagnosis of cancer to determine the changes that can be detected in blood that could be used for assessing risk or for detecting cancer at an early stage. Another approach pioneered is the use of mouse models of cancer in which cancer causing genes are turned on and blood is collected serially to identify the earliest changes in the blood that occur with tumor development. Findings from mouse studies are validated using human blood to confirm the relevance of these markers for the early detection of cancer in humans.
Follow Sam Hanash:
About The University of Texas M.D. Anderson Cancer Center: The MD Anderson Cancer Center is one of the original three comprehensive cancer centers in the United States established by the National
Alex Ermolaev
Director Of AI of Change Healthcare
AI applications on and off ever since he got his original degree in this subject more than 20 years. His experience includes enterprise AI, AI platforms/tools, NLP, imaging and self-driving cars. Alex currently works as Director of AI for Change Healthcare – one of the largest healthcare technology companies in the world.
Follow Alex Ermolaev:
About Change Healthcare: Change Healthcare is a healthcare technology company that focuses on accelerating the transformation of the healthcare system.
Li Weng
Director of AccuraGen Holdings
Li currently leads AccuraGen’s R&D. With her extensive knowledge and industry experience in genomic technology, she has spearheaded the development of a next generation sequencing (NGS)-based ctDNA assay suite which includes an amplicon-based NGS technology for SNV and fusion detection. Li is responsible for translating new technology developments into clinical actionables (LDT and potential IVD kit) for AccuraGen’s clinical labs in China as well as for GMP production. Li received her PhD in cancer biology from the University of Chicago and completed her postdoctoral studies at the Lawrence Berkeley National Laboratory where she worked on a sequencing-based assessment of human disease. She then moved to Affymetrix and later to Sequenta, where she managed the development and FDA-approval process of the company’s flagship product, a NGS-based technology for immuno profiling and MRD detection in patients with lymphoid cancer.
Follow Li Weng:
About AccuraGen Holdings: A cancer early detection company
Olivia Karpinski
Co-Founder and Director of Vivera Pharamceuticals
Ms. Karpinski is the Vice President of Sales and Marketing for Vivera Pharmaceuticals. Passionate about public health, Olivia has been in the healthcare industry for over 10 years. Her multifaceted expertise in product knowledge and business development helps her lead the sales team for Vivera while always seeking new, synergistic opportunities for the Company. Ms. Karpinski was formerly a Senior Business Analyst in the Medical Special Investigations Unit at Fortune 100 Company, Liberty Mutual. She is Lean Six Sigma certified and certified by the National Insurance Crime Bureau in special investigations and major medical fraud.
Follow Olivia Karpinski:
About Vivera Pharamceuticals: Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California.
Claire Knebl
Director of Marketing of Ritual
Follow Claire Knebl:
About Ritual: Ritual is a health technology company that is re-inventing consumer products.
Xiang Qian
Medical Director, International Medical Services of Stanford Hospital & Clinics
Dr Xiang Qian is a Pain Medicine Faculty and Physician at Stanford University. He is specialized in treating various pain conditions utilizing the combination of medicine, interventional procedure, physical therapy, and others. He is the co-director of Stanford Neuro Interventional Facial Pain Program and leads the only CT-guided interventional program in west coast of the US. Dr Qian is the Medical Director of International Medical Services at Stanford University. He helps oversee the provision of clinical care, medical chart review, and remote second opinion of Stanford international patients, along with colleagues at IMS. He helps review and optimizes telemedicine consult and international patient referral protocols, policies, and procedures. In addition, He has been working in collaboration with the faculty and hospital administrations to promote international collaborations aligned with Stanford Medicine vision. Dr Qian is the Founding President and the current Chairman of the Society of Chinese American Physician Entrepreneurs, SCAPE, one of the largest non-profit organizations of American physicians with Chinese heritage. SCAPE is a unique platform based in the United States for Chinese American Physicians to exchange ideas and to network. Members are from 50 states of the US, across over 30 different subspecialties, in both private practice and prestigious academic medical centers.
Follow Xiang Qian:
About Stanford Health Care, Stanford Hospital & Clinics, Stanford University, Stanford University School of Medicine: Stanford Hospital & Clinics operates as a hospital that provides patient care services in the United States.
Raj Khandwalla
Director of Digital Therapeutics of Cedars Sinai Medical Center
Raj Khandwalla, MD is Director of Cardiovascular Education, Assistant Professor of Medicine at Cedars Sinai Heart Institute.
Follow Raj Khandwalla:
About American College of Cardiology, Cedars Sinai Medical Center, Cedars Sinai Medical Center: Cedars-Sinai is a non-profit, academic, community-centric medical center in Los Angeles, California.
Brennan Spiegel
Director of Health Services Research of Cedars Sinai Medical Center
Brennan Spiegel is the Director of Health Services Research for Cedars-Sinai Health System and Director of the Cedars-Sinai Master’s Degree Program in Health Delivery Science. Spiegel directs a multidisciplinary team that investigates how digital health technologies, including wearable biosensors, smartphone applications, virtual reality, and social media, can improve people’s lives. His team developed the largest and most widely-documented medical virtual reality program in the world at Cedars-Sinai. Spiegel has published numerous best-selling medical textbooks, editorials, and more than 200 articles in peer-reviewed journals. He is listed in the “Top 100 Influencer” lists for digital health and virtual reality. His digital health research has been featured by major media outlets, including Bloomberg, CBS News, Forbes, Huffington Post, LA Times, NBC News, Reuters, The Washington Post and The Wall Street Journal. His virtual reality research won the 2017 “Webby Award” for best technology on the internet. His research team receives funding from the NIH, PCORI, Robert Wood Johnson Foundation, Hearst Foundation, Veterans Administration, State of California precision medicine program, and industry sources. Spiegel is Editor-in-Chief of the American Journal of Gastroenterology, the leading clinical gastroenterology journal in North America.
Follow Brennan Spiegel:
About Cedars Sinai Medical Center, Gi Health: Cedars-Sinai is a non-profit, academic, community-centric medical center in Los Angeles, California.
Mark Mactas
Board of Director of Envision Healthcare
Mark Mactas was most recently deputy chairman, president and chief operating officer for Towers Watson until his retirement in 2011. He was formerly chairman and chief executive officer of Towers Perrin (before it merged with Watson Wyatt) from 2001 to 2009. With 14,000 associates around the world, Towers Watson offers professional services in benefits, talent management, rewards, and risk and capital management. Mark is currently vice chairman of the board of Save the Children, where he has been a trustee since 2006. Since 2011, he has served on the Board of Trustees and Executive Committee of Lehigh University. In 2013, he joined the Envision Healthcare board, which offers an array of healthcare-related services to consumers, hospitals, healthcare systems, health plans and local, state and national government entities. He also was president of the Conference of Consulting Actuaries and served on its board as well as that of the American Academy of Actuaries.
Follow Mark Mactas:
About : Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
Liz Rockett
Managing Director of Kaiser Permanente Ventures
Follow Liz Rockett:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Amy Belt Raimundo
Managing Director of Kaiser Permanente Ventures
Amy Belt Raimundo joined Kaiser Permanente Ventures as managing director. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting. Immediately prior to joining Kaiser, Amy was the Chief Business Officer of digital health start-up Evidation Health founded by GE Ventures and Stanford Healthcare where she led all commercial and business development activities. Previously, Amy spent close to a decade in venture capital focused on healthcare technology as a Vice President at Covidien Ventures and Advanced Technology Ventures (ATV). She led investments in Medina Medial (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation (acquired by Abbott Vascular) including leading the international launch of the Xience drug eluting stent and managing product lines across the US, Europe and Asia. She began her career as a management consultant for APM/CSC Healthcare, optimizing operations and clinical guidelines for major hospital systems. Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Follow Amy Belt Raimundo:
About Covidien Ventures, Kaiser Permanente Ventures, MedTech Women: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Sam Brasch
Senior Managing Director; KP Venture of Kaiser Permanente Ventures
Follow Sam Brasch:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Chris Grant
Executive Managing Director of Kaiser Permanente Ventures
Chris Grant is a senior vice president at Kaiser Permanente and serves as a member of the senior executive management team. In addition to overseeing Corporate Development, Mergers and Acquisitions and Care Delivery Strategy, Grant is managing director of Kaiser Permanente’s venture capital group. Grant co-founded the investment program in 2000 and has overseen more than 50 investments in highly innovative medical technology companies. Kaiser Permanente’s successful venture investment function is designed to support the company’s health care mission while generating venture capital rates of return. Grant has served as a board director or advisor to over a dozen medical technology and service companies. Prior to the formation of the venture fund in 2000, Grant was responsible for creating, developing and managing a portfolio of new products and business lines for the organization. Before joining Kaiser Permanente in 1995, Grant held several positions on the Business Development and Financial Management Team of Rockwell International Corp. He served on Gov. Brown’s Job Creation Advisory Committee and currently serves on the boards of the East Bay Foundation for Health Education, the Pleasanton partnerships in Education Foundation and the Livermore Valley Performing Arts Council. He is a trustee of his local school district and serves as an advisor to the California Healthcare Foundation’s investment program and the Health and Science Department of Dominican University.
Follow Chris Grant:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Arthur Keledjian
Member of the Board of Directors of VG Life Sciences
Arthur Keledjian has served as a member of our Board of Directors since 2001. Arthur Keledjian has been involved with us since our inception and is a valuable addition to our Board of Directors due to his longevity with us and extensive strategic advising experience. Arthur Keledjian is responsible for procuring and managing over $10 million in annual sales with SCI – Hispana in his business development role. He is based in Los Angeles, CA. Arthur Keledjian graduated from California State University, Los Angeles with a Bachelor of Science in Business Administration & Marketing.
Follow Arthur Keledjian:
About : VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Steve Archer
Sr. Director, Electrical Dev of NeuroPace
Follow Steve Archer:
About NeuroPace: NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Steve Archer
Sr. Director, Electrical Dev of NeuroPace
Follow Steve Archer:
About NeuroPace: NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Todd Reul
Director, Clinical Outsourcing of Global Blood Therapeutics
Follow Todd Reul:
About Global Blood Therapeutics: GBT is a clinical-stage biopharmaceutical company developing its lead product candidate, voxelotor, as a therapy for sickle cell disease.
Karthikeyan Madathil
Director of Algorithms & Analytics and Director, India Operations of Atonarp
Follow Karthikeyan Madathil:
About Atonarp: Atonarp combines electronics and data processing algorithms for chemical composition analysis.
Nabil Saad
Sr. Director – Marketing & Business Development of Atonarp
Follow Nabil Saad:
About Atonarp: Atonarp combines electronics and data processing algorithms for chemical composition analysis.
Rick Devenuti
Director & Member, Audit Committee of St. Jude Medical
Rick Devenuti is President of the Information Intelligence Group (IIG), a division of EMC Corporation. With revenues of $21.7 billion in 2012 and 60,000 people worldwide, EMC is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing. Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset—information—in a more agile, trusted and cost-efficient way. Devenuti was appointed to his current position in October 2010. In his role, Devenuti oversees all aspects of IIG’s business including worldwide sales and services, channel strategy, product development, marketing, strategic business and financial initiatives, IT, technical support and the Total Customer Experience program. He previously served as the division’s chief operating officer. He joined EMC following a successful 19-year career at Microsoft Corporation. Most recently, he served as Senior Vice President of Microsoft Services and IT responsible for strategy and operational performance of Microsoft Enterprise Services, Customer Service and Support, Software-as-a-Service business and IT. In that role, he significantly expanded the Enterprise Services business, introduced support offerings resulting in improved customer satisfaction and launched Microsoft Managed Services, the company’s first software-as-a-service offering for enterprise customers. Devenuti joined Microsoft in 1987 and focused his career on creating and managing operational excellence. As chief information officer, he established metrics to measure IT value at Microsoft and integrated business processes and business acumen into IT, resulting in efficiency gains for end users and cost savings for the company. Before becoming CIO, Devenuti was vice president of worldwide operations where he directed all activities related to Microsoft product information and release management, manufacturing, distribution, and transaction processing. He also held numerous operational positions at Microsoft including general manager of North American operations, general manager of U.S. sales operations, director of financial analysis, controller and cost accounting manager. Prior to Microsoft, he spent four years at Deloitte Touche as a Senior Accountant. Devenuti earned his Bachelor of Science Degree in Accounting from University of Washington. He currently serves on the Boards Of Directors for St. Jude Medical and Convergys Corporation.
Follow Rick Devenuti:
About Dell EMC: St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac,
Jamey Nielsen
Director of R&D of Zenflow
Jamey Nielsen is the ddirector of R&D at Zenflow, Inc.
Follow Jamey Nielsen:
About Zenflow: Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Jack Zhang
CEO,CSO, and Director of Amphastar Pharmaceuticals
Jack Y. Zhang, Ph.D. has served as Amphastar Pharmaceutical’s Chief Executive Officer and as a member of the Board of Directors since its inception in 1996. He has also served as Amphastar’s Chief Science Officer since 2005 and as the President from 1996 until June 2013. Dr. Zhang has over 35 years of experience in chemistry, physics, management, and training including operations management of a chemical manufacturing facility with more than 2,000 employees to the start-up of an analytical laboratory serving defense cleanup. He is the co-founder of Applied Physics & Chemistry Laboratory (“APCL”), a full service, chemical analytical laboratory in Chino, California, where he held the position of President for 15 years. Dr. Zhang is named as the inventor on several U.S. and foreign patents and has authored numerous academic publications. He received a Ph.D. in Chemistry from the State University of New York at Stony Brook and was a Post Doctoral Research Associate at the California Institute of Technology.
Follow Jack Zhang:
About Amphastar Pharmaceuticals: Amphastar Pharmaceuticals specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic.
Kenneth Kelley
Co-Founder, CEO & Director of PaxVax
Mr. Kelley co-founded PaxVax in early 2007 and serves as the Company’s Chief Executive Officer and Executive Chairman. Mr. Kelley brings to PaxVax thirty years of experience in biotechnology (IntraBiotics, Integrated Genetics), venture capital (K2 BioVentures, Latterell Venture Partners, Institutional Venture Partners), and strategic management (McKinsey & Company). During his career, Mr. Kelley has funded 36 early stage biotechnology and medical device companies, fifteen of which became public. As founder/CEO and Chairman of IntraBiotics Pharmaceuticals, Inc., he raised over $200M and took the company public in 2000 (NASDAQ: IBPI). Mr. Kelley also serves as Chairman of the Board for Halozyme (NASDAQ: HALO) and Fluxion Biosystems. Mr. Kelley earned an M.B.A. from Stanford University and a B.A. in Biochemical Sciences from Harvard University.
Follow Kenneth Kelley:
About PaxVax: PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Nick Arora
Director, Medical Information of xCures
Nick A. Arora is an entrepreneur, investor and advisor within emerging technologies and health. He is Director, Medical Information at xCures an AI-based precision oncology platform that tightly integrates cancer research and care. He also serves as Chief Health Advisor of Rymedi, a health/life sciences company improving the process of capturing, tracking & sharing data to expand markets and improve health & wellness. Previously, Nick has been Chief Business Development Officer at Solaster, a consumer-driven health ecosystem creating global interoperability of decentralized, distributed health applications and blockchains. He was a founding member and Chief Strategy Officer at LINKCHAIN, a blockchain-enabled supply chain company where he led key strategic initiatives including the company’s partnership with GoChain. Nick has also served as Chief Business Officer and Health Lead at BlockRake, a premier capital markets consulting firm. Nick has lectured on blockchain, supply chain and health at Stanford University and has been the Co-Host of Blockchain in Health Care SF, the largest blockchain health meetup organization in Silicon Valley. An Ivy League graduate from Yale University and former Medical Doctor (M.D.) Candidate, Nick’s research at Johns Hopkins University has been published in top scientific journals across the world. He has also advised healthcare organizations globally and founded multiple businesses, including CrankOut, a health tech company that was featured in Entrepreneur.
Follow Nick Arora:
About xCures: xCures is an AI-based precision oncology platform that tightly integrates cancer research and care.
Michael Blaszyk
Director of Sound Physicians
Director at Sound Physicians.
Follow Michael Blaszyk:
About Dignity Health, Sound Physicians: Sound Inpatient Physicians is a physician services organization focused on driving improvements in quality, satisfaction and efficiency.
Bill Perry
CEO, Director of Deep Blue Medical Advances
Bill Perry is the CEO and Director at Deep Blue Medical Advances.
Follow Bill Perry:
About Deep Blue Medical Advances: Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence.
Kelly Mabry
Director of Research & Development of Tangible Science
Follow Kelly Mabry:
About Tangible Science, VIC Technology Venture Development: Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.
David Kargas
Director of Marketing Communications of The Clorox Company
David Kargas, a marketing director at the Clorox Company, knows nothing about cleaning. In his eight years with Clorox, David has developed dozens of brand engagement programs for brands such as Hidden Valley Ranch, Kingsford Charcoal and Fresh Step Litter, but none for Clorox Bleach. At the Clorox Company, he is recognized as the only staff member to work on programs with a cast member of both the original and late 2000s version of 90210. Prior to joining the Clorox Company, David spent years as a yes man and scapegoat at advertising and public relations agencies. His career highlights include getting his client’s Smart Dog thrown out of Camden Yards ballpark at an event held to honor its inclusion at Camden Yards ballpark. When not working, David enjoys, baseball, hiking and telling his three kids that’s probably enough Xbox now.
Follow David Kargas:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Vikram Sarma
Senior Director Of Marketing of The Clorox Company
Vikram Sarma is the Senior Director Of Marketing at The Clorox Company.
Follow Vikram Sarma:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Elizabeth Tung
Associate Director , National Shopper Marketing of The Clorox Company
Follow Elizabeth Tung:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Brian Freed
Managing Director, Executive Officer of Caricord
Executive Director Dr. Freed has over 30 years of experience and over 80 publications in the fields of stem cell banking and histocompatibility. He is a member of the American Society for Histocompatibility and Immunogenetics, AABB, the American Society of Transplantation, and the American Society for Blood and Marrow Transplantation. Dr. Freed is a diplomate of the American Board of Histocompatibility and Immunogenetics.
Follow Brian Freed:
About Caricord: CariCord is an umbilical cord blood bank that is both public and private while also holding rigorous FDA licensure.
Satoshi Sugie
Representative Director, CEO, and Founder of WHILL
After working at the NISSAN Technical Center, He co-founded the WHILL Project in 2011.World Economic Forum Davas Meeting and a GSC Japan member.
Follow Satoshi Sugie:
About WHILL: WHILL designs and creates personal mobility products for indoor and outdoor applications.
Manu Kanwar
Director Process Development of Kite Pharma
Follow Manu Kanwar:
About Kite Pharma: Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
David Kim
Director, Global Supply Chain of Kite Pharma
Follow David Kim:
About Kite Pharma: Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
John Rossi
Associate Director of Kite Pharma
Follow John Rossi:
About Kite Pharma, Kite Pharma, Kite Pharma: Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Reggie Foster
Sr. Director of Labeling, Logistics and Packaginging Engineering of Kite Pharma
Follow Reggie Foster:
About Kite Pharma: Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Nicholas A. Boyle
Co-Founder, President, CEO, and Director of Abintus Bio
Nicholas A. Boyle, Ph.D., is vice president, corporate strategy and business development at Tocagen. Previously, Dr. Boyle was director of corporate development at Spectrum Pharmaceuticals Inc. Among other responsibilities at Spectrum, Dr. Boyle completed numerous strategic licensing agreements, including transactions valued up to approximately $700 million for a Phase 3 cancer compound with Allergan, Nippon Kayaku and Handok. During his scientific career, Dr. Boyle was team leader for antiviral and anticancer drug discovery programs at Biota Inc. and synthesized anti-stroke drug candidates at SmithKline Beecham (now GSK). Dr. Boyle is an author or inventor on 15 scientific articles/patents. Nicholas holds a master’s degree in business administration from the University of California, San Diego, a doctorate in organic chemistry from Sheffield University and a bachelor’s degree in medicinal chemistry. He completed his post-doctoral research at The Scripps Research Institute, was a visiting scholar at The University of North Texas and received a Monbusho Fellowship to conduct research at NIAIR, Tsukuba, Japan.
Follow Nicholas A. Boyle:
About Abintus Bio, Tocagen: Abintus Bio engages in the field of in vivo immune cell reprogramming.
Dr. Karen Aboody
Director, Founder & Chief Scientific Officer of TheraBiologics
Associate Professor Neurosciences/Neurosurgery, City of Hope Comprehensive Cancer Ctr & Beckman Research Inst. ?Pioneered pre-clinical development of NSC-mediated cancer treatment. First to translate to human clinical trials ?MD, Mount Sinai School of Med; Post-Doctorate, Mass General Hosp/Harvard Med School; BA, Univ. of Pennsylvania Industry experience: Senior Scientist, Layton BiosSci She received the American Association of Neurological Surgeons Young Investigator award in 2000, and the American Society of Gene Therapy Outstanding New Investigator Award in 2008. She also holds two issued U.S. and international patents and has authored numerous publications in peer-reviewed journals. She recently founded a clinical stage biopharmaceutical company, TheraBiologics Inc, to support clinical development of neural stem cell-mediated cancer therapies.
Follow Dr. Karen Aboody:
About TheraBiologics: TheraBiologics develops a proprietary human NSC platform for cancer treatment.
Fritz Eibel
Board of Directors of MolecularMD
Mr. Eibel brings more than two and a half decades of broad-based in vitro diagnostics and life science experience focused primarily on new and emerging growth opportunities. He most recently served as Head of Genetic Analysis Commercial Operations at Agena Bioscience, which was previously the Genetic Analysis Division of Sequenom Inc. Mr. Eibel was involved with the sale and integration of the division to Telegraph Hill Partners. Prior to his time at Sequenom and Agena, he held similar leadership positions at Gen-Probe Inc., Life Technologies Inc., and Roche Diagnostics Corp. Mr. Eibel also serves on the Board for MolecularMD, a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial services for targeted cancer therapies. He holds a Bachelor of Arts and Sciences in Biology and Chemistry from Indiana University and a MBA from University of Indianapolis.
Follow Fritz Eibel:
About : MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Fritz Eibel
Board of Directors of MolecularMD
Mr. Eibel brings more than two and a half decades of broad-based in vitro diagnostics and life science experience focused primarily on new and emerging growth opportunities. He most recently served as Head of Genetic Analysis Commercial Operations at Agena Bioscience, which was previously the Genetic Analysis Division of Sequenom Inc. Mr. Eibel was involved with the sale and integration of the division to Telegraph Hill Partners. Prior to his time at Sequenom and Agena, he held similar leadership positions at Gen-Probe Inc., Life Technologies Inc., and Roche Diagnostics Corp. Mr. Eibel also serves on the Board for MolecularMD, a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial services for targeted cancer therapies. He holds a Bachelor of Arts and Sciences in Biology and Chemistry from Indiana University and a MBA from University of Indianapolis.
Follow Fritz Eibel:
About : MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Maya Fujita
Director of NapaJen
Follow Maya Fujita:
About : NapaJen Pharma is a Pharmaceutical company designed to supply drugs in effective methods to end up active form in the organ.
Yanfeng Wang
Exec. Director of Ionis Pharmaceuticals
Yanfeng Wang, Ph.D. has over 20 years of industry experience in both large Pharma (Novartis and Merck) and Biotech (Ionis) companies, including 7 years in Nonclinical Tox/DMPK and 14 years in PK/Clinical Pharmacology. Yanfeng has spent much of his career supporting Oncology drug development. He has contributed to multiple NDA submissions including Tasigna, Signifor; Odomzo, Zykadia, and Midostaurin, as well as sNDA submissions for Glivec, Sandostatin LAR, Ritalin LAR and Focalin LAR new formulation development all at Novartis. Currently Yanfeng is an Executive Director of the PK and Clinical Pharmacology department at Ionis, a leading biopharmaceutical company specialized in antisense oligonucleotides drug development. At Ionis, he has the opportunity to support another NDA submission for Nusinersen, a novel and first-in-class therapy for paediatric patients with spinal muscular atrophy. Dr. Wang has published over 70 papers in refereed journals. He earned his Ph.D. in pharmaceutical sciences at the University of Minnesota under the direction of Professor Ronald Sawchuk. He is a member of AAPS, ASCPT, ASCO, ISSX, SAPA.
Follow Yanfeng Wang:
About Ionis Pharmaceuticals: Ionis Pharmaceuticals is a drugmaker company.
Claus Rentel
Director, Analytical Development / Quality Control of Ionis Pharmaceuticals
Follow Claus Rentel:
About Ionis Pharmaceuticals, Ionis Pharmaceuticals: Ionis Pharmaceuticals is a drugmaker company.
Brent Golec
Associate Director, Pharmaceutical Development of Ionis Pharmaceuticals
Brent Golec, Associate Director of Pharmaceutical Development at Ionis Pharmaceuticals, has more than 21 years of experience in formulation development, process engineering, and GMP manufacturing of oral and parenteral dosage forms. His expertise includes aseptic manufacturing, lyophilization, and prefilled syringe technologies. In his role at Ionis, Mr. Golec has provided real-time resolution of GMP drug product manufacturing issues, selected and managed CDMOs, employed quality engineering principles to enhance the oligonucleotide drug product manufacturing process, and was a main contributor in establishing Ionis’ combination product development process. Additionally at Ionis he has led and provided strategic direction for the development of the prefilled syringe commercial dosage form for Volanesorsen. Previously, Mr. Golec served as Principal Scientist, Head of Formulation Development at Anadys Pharmaceuticals. There, his responsibilities included designing and executing solid dosage formulation and GMP manufacturing strategies, as well as developing oral suspension formulations. From 2005 to 2007, Mr. Golec served as Process Engineer at Amylin, where his work on Bydureon™ included leading the CMC prefilled syringe project sub-team for the Amylin/Alkermes/Lilly Alliance and designing, scaling up the commercial manufacturing process, along with engineering support for design/construction of the Amylin Ohio sterile microsphere production facility. From 1999 to 2005 as Senior Scientist for Pfizer Global Research and Development, he led the development and GMP manufacturing of both parenteral and solid oral dosage formulations. From 1995 to 1999, he was part of a research team that created innovated tissue targeted ultrasound imaging agents for injection. From 1994 to 1995, Mr. Golec worked in the field of DNA technology. Mr. Golec received a B.S. in Biochemistry and Cell Biology from the University of California, San Diego in 1994.
Follow Brent Golec:
About Ionis Pharmaceuticals: Ionis Pharmaceuticals is a drugmaker company.
Frederick Muto
Member of the Board of Directors of Ionis Pharmaceuticals
Frederick Muto has served as a Director of Isis since March 2001. Muto joined the law firm of Cooley LLP, outside counsel to Isis, in 1980 and became a partner in 1986. He is Chair of the firm’s Business Department and a founding partner of Cooley LLP’s San Diego office.
Follow Frederick Muto:
About : Ionis Pharmaceuticals is a drugmaker company.
Dean Felsher
Professor, Oncology and Pathology, Stanford University; Director of Research, Oncology, Stanford of Apostle
Follow Dean Felsher:
About : Apostle Inc is a provider of innovative technologies and services for public health and life sciences.
Russell Chan
Co-Founder & R&D Director of Gense Technologies
Follow Russell Chan:
About Gense Technologies: Gense Technologies is a biotech startup developing state-of-the-art technology for their patented hand-gesture recognition smartwatch.
Kiril Tzvetkov
Senior Director, Procurement & Global Supply Chain of Advanced Bionics
Follow Kiril Tzvetkov:
About Advanced Bionics: Advanced Bionics Corporation develops implantable neurostimulation devices.
Nick Phillips
Director of Digital Media / Editor in Chief of Med-X
Follow Nick Phillips:
About Med-X, The Marijuana Times: Med-X innovates, researches, and develops a variety of all-natural and alternative solutions to harmful pharmaceutical products.
Liangyi Zhang
Associate Director, CMC Analytical of ADC Therapeutics
A well-rounded leader in analytical development of monoclonal antibodies,bispecifics and antibody drug conjugates (ADC). Served as an analytical project leader to ensure that all analytical development, process analytics, impurity analysis and quality control of antibody and ADC products are proactively identified and addressed to meet the regulatory and business needs.
Follow Liangyi Zhang:
About ADC Therapeutics: ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Ryan Bloom
Director, Business Development and New Product Planning of BlueRock Therapeutics
Ryan Bloom is the Corporate Development at BlueRock Therapeutics.
Follow Ryan Bloom:
About BlueRock Therapeutics, Factor 14: It is a regenerative medicine company.
Life Griffith
Executive Director of U.S. Department of Veteran Affairs
Mr. Life D. Griffith is the Founder and Executive Director of Veterans Health Solutions, a non-profit mutual benefit corporation that is the premier cannabis education resource for the veteran communities. He has served the country for 19 years as a Combat Medic and has a passion for service-based leadership. Prior to creating Veterans Health Solutions, Mr. Griffith served as a Legal Administrative Specialist & Minority Veteran Program Director for the West Los Angeles Department of Veterans Affairs. His responsibilities included processing claims, evaluating medical evidence and serving as the Veteran Liaison for underserved veterans. As the Minority Veteran Program Director, Mr. Griffith and his team provided education to veteran organizations and veteran families about the benefits offered through the Veterans Benefits Administration. Mr. Griffith is a certified Cannabis instructor from the Cannabis Career Insitute and Cannabis Training University and holds a Master’s of Science Degree in Business Management with an emphasis in Leadership from the American College. He is an active community leader and member of the Omega Psi Phi Fraternity, Inc., Veteran of Foreign Wars, The American Legion, and Disabled Veterans of America.
Follow Life Griffith:
About U.S. Department of Veteran Affairs: The United States Department of Veterans Affairs is a government-run military veteran benefit system.
Matthew T. Plavan
CEO & Director of Thermogenesis
Matthew Plavan was appointed president and chief executive officer in September 2019. He joined Arcadia as chief financial officer three years earlier and most recently, also served as president of Arcadia Specialty Genomics, a strategic business unit delivering innovations in hemp. Prior to joining Arcadia, Mr. Plavan served as CEO and board member of Cesca Therapeutics, Inc., and COO of ThermoGenesis Corp. He also led the finances, as CFO, of two high-tech private equity backed companies, positioning each for successful exits, following executive and senior management tenures at both McKesson and Ernst & Young, LLC. Mr. Plavan is a certified public accountant (inactive) and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.
Follow Matthew T. Plavan:
About Arcadia Biosciences, Thermogenesis: Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Dalip Sethi
Senior Director, Research & Development of Thermogenesis
Follow Dalip Sethi:
About Thermogenesis: Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Mark Stolper
Chairman of the Board of Directors of CompuMed
Mark Stolper has served as our Executive Vice President and Chief Financial Officer since 2004 and prior to that was an independent member of our Board of Directors. Mark Stolper is responsible for all aspects of the Company’s financial functions and disciplines. Prior to joining us, Mark Stolper had diverse experiences in investment banking, private equity, venture capital investing and operations. Mark Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc., executing mergers and acquisitions, public and private financings and private equity investments with Saratoga Partners LLP, an affiliated principal investment group of Dillon Read. After Dillon Read, Mark Stolper joined Archon Capital Partners, which made private equity investments in media and entertainment companies.Mark Stolper also worked for Eastman Kodak, where Mark Stolper was responsible for business development for Kodak’s Entertainment Imaging subsidiary ($1.5 billion in sales). Mark Stolper was also co-founder of Broadstream Capital Partners, a Los Angeles-based investment banking firm focused on advising middle market companies engaged in financing and merger and acquisition transactions. Mark Stolper graduated with a liberal arts degree from the University of Pennsylvania and a finance degree from the Wharton School. Additionally, Mark Stolper earned a postgraduate Award in Accounting from UCLA.
Follow Mark Stolper:
About RadNet: CompuMed offers a comprehensive cardiac screening package with ECG over-reads, remote consultation, cardiograms, and more.
Dru Wynings
Senior Director Of Marketing of DSP Concepts, Inc.
Follow Dru Wynings:
About DSP Concepts, Inc.: Silicon Valley based leader in the Audio of Things market and the creator of Audio Weaver, the platform that makes audio innovation easy
Reid Rutherford
Director of DSP Concepts, Inc.
Follow Reid Rutherford:
About : Silicon Valley based leader in the Audio of Things market and the creator of Audio Weaver, the platform that makes audio innovation easy
Skip Vaccarello
Director of DSP Concepts, Inc.
Follow Skip Vaccarello:
About : Silicon Valley based leader in the Audio of Things market and the creator of Audio Weaver, the platform that makes audio innovation easy
Skip Vaccarello
Director of DSP Concepts, Inc.
Follow Skip Vaccarello:
About : Silicon Valley based leader in the Audio of Things market and the creator of Audio Weaver, the platform that makes audio innovation easy
Travis Foegler
Marketing Director of CorTechs Labs
Follow Travis Foegler:
About CorTechs Labs: CorTechs Labs is a developer of a brain image analysis software used to offer better clinical insight through quantitative imaging.
Yimin Zou
CEO & Director of VersaPeutics
Yimin Zou graduated from Shanghai Fudan University and was a CUSBEA (China and United States Biochemistry Examination and Application Program) student and received his Ph. D. from University of California, Davis, and San Diego, in 1995. He did his postdoctoral fellowship at the University of California, San Francisco from 1996 to 2000 and was an Assistant and Associate Professor at the University of Chicago from 2000 to 2006. He joined the faculty in July 2006.
Follow Yimin Zou:
About VersaPeutics: VersaPeutics is a biotech startup devoted to finding treatment for disorders of the nervous system.
